ANGPTL4 and neoplasm: In triple negative breast cancer (TNBC) ANGPTL4 and VEGFA together to heparin-binding epidermal growth factor (HB-EGF) play a pivotal role in the acquisition of tumor aggressiveness regulating tumor angiogenesis [139].